Reconciling the contrasting findings on MitraClip, and implications for the management of functional mitral...

Last year, the first two randomised controlled trials (RCT) looking at percutaneous edge-to-edge repair (MitraClip, Abbott) for the management of functional mitral regurgitation (MR)...

ACC 2019: TAVI moves to the mainstream with new findings in low-risk patients

Evidence for the use of transcatheter aortic valve replacement (TAVI) as standard therapy is mounting, with the release of data from two major new...

CRT 2019: Evolut R superior to surgery at one year in intermediate-risk patients

A subanalysis from the SURTAVI trial has found that transcatheter aortic valve implantation (TAVI) with Evolut R in intermediate-risk patients has lower rates of...

MitraClip can be used to treat secondary mitral regurgitation in the USA

The US FDA has approved a new indication for percutaneous edge-to-edge repair (MitraClip, Abbott), allowing its use for the reduction of moderate-to-severe or severe...

Robert W Yeh

Olaf Wendler

Juan F Granada

(Visited 2,543 times, 1 visits today)